362.1: Increases in donor-derived cell-free DNA prior to biopsy proven rejection in kidney transplant.
Jonathan S. Bromberg(University of Maryland, Baltimore), Milagros Samaniego(Henry Ford Health System), Hossein Tabriziani(Natera (United States)), Kyle Marshall(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Philippe Gauthier(Centre de Coopération Internationale en Recherche Agronomique pour le Développement), Madeleine Armer-Cabral(Natera (United States)), Zachary Demko(Natera (United States)), Navchaten Kaur(Natera (United States)), Sangeeta Bhorade(University of Chicago)
Cited by 1
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
|Proceedings of the National Academy of Sciences|2009|342